The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
On May 28, Veracyte reported a 21% revenue growth in its Q1 2026 results. Non-GAAP gross margins expanded to 76%. Following strong cash generation, the company raised its 2026 guidance.